Genetic & Genomic MedicineeLifePeer-reviewed
Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
Shek Man Chim, Kristen Howell, John Dronzek…·Harikiran Nistala
The paper identifies SLC39A5 as a gene whose loss-of-function variants are associated with reduced type II diabetes risk and improved liver function in metabolic disorders.